Now in Development

Insulin pump therapy, finally affordable for India

940,000 Indians live with Type 1 Diabetes. Less than 1% can afford a pump. We are building the IY-1 — a medical-grade insulin pump at a fraction of what imported options cost today.

Get in Touch Learn about IY-1 →
Current imported pumps
₹3–6 Lakhs
IY-1 target price
Up to 90% less
Register Your Interest →
Made in India · Hindi + 5 regional languages · Pan-India service network
9.4L
T1D patients in India
<1%
can currently afford a pump
80–90%
lower price than existing options
60%
savings on annual consumables
The Problem

Life-saving technology, priced out of reach

Insulin pump therapy dramatically improves outcomes for T1D patients — better time in range, fewer hypoglycemic episodes, improved quality of life. Yet almost no Indian family can afford one.

💊

Current pump cost: ₹3–8 Lakhs

Global brands have no incentive to reduce prices for emerging markets.

📉

51.4% can't afford insulin

More than half of Indian households with diabetes cannot afford even basic insulin, let alone a pump.

🌍

Metro-only service

Existing brands serve only 6–8 metro cities. Tier 2 and Tier 3 India is entirely left out.

🎯

Our mission: access, not just profit

Insulin Yogi is a social entrepreneurship venture built to change this equation for every Indian family.

The Solution

Introducing the IY-1

IY-1

India's first affordable, medically capable insulin pump — designed from the ground up for Indian patients, conditions, and budgets.

  • Priced to be accessible to middle-income Indian families — up to 90% less than imported pumps
  • 16 profiles with 24 periods in each proile
  • Bolus calculator with standard safety features
  • Open CGM protocol
  • Smartphone app with Hindi + 5 regional language support
  • IPX7 waterproof rating · 4-year warranty
  • Pan-India service network via 3PL partners
  • CSR subsidy model for BPL families (down to ₹0)
Feature Premium Brands IY-1
Device Price ₹3–6 Lakhs Up to 90% less*
Annual Consumables ₹45–60K / year ~60% lower
Service Coverage Metro only Pan-India
Language Support English only Hindi + 5 languages
CGM Compatibility Proprietary only Open protocol
CSR / NGO Channel None Yes — free for BPL

* Exact pricing will be shared with registered contacts. Register your interest →

Our Team

Leadership

Insulin Yogi is led by a team of purpose-driven entrepreneurs, engineers, and operators united by a single goal — putting life-saving technology within reach of every Indian family.

Amit Rana
Amit Rana
Honarary CEO

Three-time tech entrepreneur with 20+ years building and scaling companies. Co-built a 350+ member engineering firm to one of Bengaluru's most notable tech exits — one of only 13 companies worldwide certified under the Google Developer Agency Program. An angel investor, mentor, and full-time farmer, Amit serves Insulin Yogi as Honarary CEO — driven by the conviction that access to life-saving insulin therapy should never be a privilege.

Viswanath
Viswanath Hebbale
Chief Technology Officer

Mechanical Engineer turned Aerospace Engineer with over 40 years of experience spanning rocket engine design, large commercial aircraft, business jets, regional jets, fighter aircraft, and UAS design & development. Has built test facilities for qualification and certification testing of fighter aircraft, and led mechanical systems design, systems engineering, and flight testing across multiple aircraft programmes. In the engineering services domain, has served as domain consultant, technical pre-sales lead, and customer engagement manager — owning end-to-end responsibilities from project acquisition and team recruitment to workflow development, technical training, and rigorous project reviews to deliver the highest levels of customer satisfaction.

Dinakaran
P. Dinakaran
Chief Operating Officer

Seasoned pharmaceutical leader and management consultant with four decades of experience across India's healthcare industry. At Novo Nordisk, served as Country Manager – Sri Lanka (P&L), Senior Manager – Market Access & Public Affairs, and Senior Manager – Training & Development, driving national diabetes advocacy, policy engagement with government bodies, and capability development. Landmark contributions include establishing Centers of Excellence for Type 1 Diabetes, leading the Assam Affordability Program (2022), heading the Novo Nordisk Education Foundation, and organising flagship forums including India Pharma 2016 and the Afro-Asian Diabetes Conclave. Earlier tenures span Abbott, Wockhardt, Aster Life Sciences, Boots India, and others. An accredited CME programme developer, academic author, and contributor to the CDiC Textbook of Pediatric Diabetes — and Founder of Stridewell, building active workplaces for healthy living.

Our Advisors & Mentors

Backed by exceptional leaders

Insulin Yogi is guided by a distinguished group of mentors spanning medicine, engineering, technology, and finance — united by a belief that India deserves world-class healthcare.

Dr. Kota Harinarayana

Dr. Kota Harinarayana

Padma Shri · PhD (IIT Bombay) · Chief Designer, HAL Tejas LCA

The visionary behind the LCA Tejas — India's first indigenously designed Light Combat Aircraft. Programme Director and Chief Designer who led the team that first flew the Tejas Technology Demonstrator on January 4, 2001. Recipient of the Padma Shri and DRDO Distinguished Scientist Award. Founder Chairman, General Aeronautics (IISc incubatee).

Dr. S. Sathyanarayana Srikanta

Dr. S. Sathyanarayana Srikanta

MD (AIIMS) · PhD · FACE · FRCP Hon (London)

One of India's most distinguished endocrinologists and diabetologists. Former faculty at Harvard Medical School and Clinical Investigator at the National Institutes of Health, USA, at age 29. Former Head of Endocrinology at SGPGI and Visiting Clinician at Mayo Clinic and the University of Michigan. Medical Director, Samatvam Endocrinology Diabetes Center, Bengaluru since 1993.

Balakrishna Adiga

Balakrishna Adiga

38+ years in IT · Former Director, IBM · MD, Savvis Communications

Seasoned technology leader with 20 years at IBM across multiple geographies, serving as Director — Strategic Outsourcing Sales. Subsequently Managing Director at Savvis Communications and Corporate Advisor at CenturyLink. Active angel investor and mentor for technology startups; serves on boards of several technology companies in India and abroad.

Subba Rao Amarthaluru

Subba Rao Amarthaluru

CA · Former Group CFO, GMR Infrastructure · MD Finance, Sanmar Group

Distinguished finance leader with four decades across India's largest infrastructure and industrial conglomerates. Nearly 13 years as Group CFO at GMR Infrastructure, overseeing landmark transactions including the company's IPO. Former MD Finance at The Sanmar Group. Independent Director and Audit Committee Chairman for GMR airports; currently on the boards of Linde, SOBHA, and Delhi Duty Free Services.

Shruthi Muniyappa

Shruthi Muniyappa

CA · LLB · Founder, Sarus Advisory Services · Governing Body, Sandur Kushal Kala Kendra

Chartered Accountant and law graduate with formative experience at PricewaterhouseCoopers and Deloitte Touche Tohmatsu India, specialising in audit, due diligence, and M&A advisory. Since founding Sarus Advisory Services in 2014, she has partnered with businesses at critical growth stages — offering insight that goes beyond compliance to enable confident, well-structured decision-making. Her approach is hands-on, detail-oriented, and anchored in building enduring financial foundations. She serves as Governing Body Member and Secretary at Sandur Kushal Kala Kendra, supporting artisan communities, and is a Founding Member and Director of Insulin Yogi.

Bhagavan Srinivasan

Bhagavan Srinivasan

Director, Insulin Yogi · BSc BE (Ele) · 5 Decades in Industrial Automation & Business

An entrepreneur for over two decades with nearly five decades of experience spanning Indian and international business, projects, and automation — including two M&A transactions with global MNCs. Brings a practitioner's perspective on diabetes as a Type 2 Diabetes patient, an early adopter of CGM (Continuous Glucose Monitoring), and an insulin user for over a decade. A volunteer at Samatvam with deep knowledge of both T1 and T2 diabetes. Previously a mentor for a non-invasive glucose measurement startup. His work in pharmaceutical automation spans cross-contamination control and regulatory audit support for USFDA, UKMCA, TGA Australia, and SAHPRA (South Africa). Associated with ASHRAE & ISHRAE; communicates in Kannada, Tamil, Hindi, English, and German.

Dr. Kavitha Muniraj

Dr. Kavitha Muniraj

MBBS · PGDD · FEDM · FACE (USA) · Director (Medical), Samatvam Science & Research Center

Physician-scientist with over two decades in endocrinology, diabetes, and clinical research. Has held senior leadership roles at Samatvam Endocrinology Diabetes Center, including Director of Research and Director of Medical Services. Her clinical research career spans bioequivalence trials through Phase 3/4 studies, pharmacovigilance, and aggregate reporting, with roles as medical monitor and investigator across multiple national and international trials in diabetes, cardiovascular disease, and dyslipidemia. Expertise in translational research, clinical pharmacology, digital health, and precision medicine. Author of 70+ case-based abstracts with a paper recognised as a Top Cited Article in the American Journal of Medical Genetics (2024–25).

V A Ramakrishna

V A Ramakrishna

B.Tech, NIT Surathkal · PGDM, IIM Bangalore · Founder, Learning Labs · Trustee, Samatvam

Over 30 years of professional experience spanning technical, sales, account management, marketing, and global alliance management in the IT software services industry — including international stints in Singapore, Malaysia, and the USA. Founder and Director of Learning Labs, a skill assessment company. A Trustee of SNEHA Trust, an NITK alumni initiative supporting education for the underprivileged. Ramki's commitment to Insulin Yogi is deeply personal — his son Shreyas has lived with Type 1 Diabetes for nearly 27 years. A volunteer at Samatvam for over two decades and currently serving as Trustee, he brings both lived experience and institutional depth to the cause of accessible T1D care.

"There are 940,000 T1D patients in India. For every child who gets a pump, there are 99 who cannot. Insulin Yogi exists to change this equation."
— Insulin Yogi Mission Statement
Join Our Team

We're hiring

We are a small, mission-driven team building India's most affordable insulin pump. If you want your work to matter — to the 940,000 children and adults living with Type 1 Diabetes in India — we'd like to meet you.

Open Role
Lead Designer — Mechatronics
Full-time · Bangalore (preferred) · Reports to CEO / CTO

Own the electromechanical design of the IY-1 pump from current prototype through design freeze, verification, and transfer to manufacturing. This is a hands-on technical leadership role — you will be the primary design owner of the pump's mechanical, electrical, and systems architecture.

Must Have
  • 5–7 years in product design & development — medical device or regulated electromechanical product strongly preferred
  • Full product lifecycle experience: concept → detailed design → prototyping → verification → manufacturing transfer
  • Proficiency in SolidWorks, MATLAB/Simulink, and thermal analysis tools
  • Working knowledge of ISO 13485, ISO 14971, IEC 60601-1
  • Ability to author design specs, DHF inputs, and engineering change documents
Apply for this Role →
Open Role
Lead — Quality Assurance & Regulatory
Full-time · Bangalore (preferred) · Reports to CEO

Build our Quality Management System from scratch, own verification and validation, drive standards compliance, and lead the CDSCO Class C product certification process. You will be the single point of ownership for quality, testing, and regulatory — planning it, executing it, and getting us through certification.

Must Have
  • 8+ years in medical device QA & regulatory — direct experience with Class II/III FDA or Class C CDSCO devices required
  • Hands-on experience building a QMS per ISO 13485 from scratch and surviving audits
  • Strong working knowledge of IEC 60601-1, IEC 60601-2-24, ISO 14971, IEC 62304
  • V&V ownership: master plans, test protocols, execution, data analysis, summary reports
  • Technical writing for regulatory submissions, risk files, and compliance documentation
Apply for this Role →
Get Involved

Register your interest

Be among the first to receive pricing, availability updates, and partnership opportunities. We welcome investors, CSR partners, hospitals, NGOs, and medical professionals.

contact@insulinyogi.com Bengaluru, India